Fatehpur

Postpartum hemorrhage is a leading cause of illness and death among mothers worldwide, accounting for 25% of pregnancy-related deaths. It can happen unexpectedly without risk factors. This research studies the use of tranexamic acid, a medicine that helps reduce bleeding, as an additional treatment to other uterotonics before cesarean section surgeries to see if it reduces blood loss. Women in the study will be divided into two groups. One group will receive a 1 gram dose of tranexamic acid dissolved in 100 ml of normal saline given by intravenous infusion 10 minutes before the skin incision for the cesarean delivery. The other group will receive a placebo of 100 ml normal saline infusion at the same time before the incision. This design allows comparison of blood loss during and after surgery. Participants will be monitored to measure the amount of blood lost from the start of the surgical incision until 24 hours after the cesarean section. Researchers will evaluate how much blood is lost to assess the effect of tranexamic acid. Women will be followed closely during this period to ensure safety and collect data on blood loss and any related outcomes.